Advertisement

Reactions Weekly

, Volume 1744, Issue 1, pp 138–138 | Cite as

Gefitinib/osimertinib

Development of resistance in non-small cell lung cancer: case report
Case report
  • 14 Downloads

Reference

  1. Pisapia P, et al. EGFR exon 19 deletion switch and development of p.L792Q mutation as a new resistance mechanism to osimertinib: A case report and literature review. Translational Cancer Research 8 (Suppl. 1): S64-S69, No. 1, Jan 2019. Available from: URL: http://doi.org/10.21037/tcr.2018.09.13 - Italy

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations